Barclays Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price objective upped by research analysts at Barclays from $610.00 to $674.00 in a research report issued on Monday. Barclays‘s price target would suggest a potential upside of 17.30% from the stock’s current price.

Other equities analysts have also recently issued reports about the stock. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday. Truist Financial upped their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $610.95.

Intuitive Surgical Stock Down 1.6 %

Shares of ISRG traded down $9.46 during trading on Monday, reaching $574.59. 1,391,095 shares of the company traded hands, compared to its average volume of 1,954,819. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $204.66 billion, a PE ratio of 92.27, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock has a 50-day simple moving average of $547.16 and a 200-day simple moving average of $505.21.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,453 shares of company stock worth $22,059,506. Company insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares during the period. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its stake in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, State Street Corp boosted its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.